A Clinical Trail to Study The Effect Of Siddha Drug Mithran Ambu Chooranam In Patients Having Urolithiasis(Vatha kalladaippu)
- Conditions
- Unspecified renal colic,
- Registration Number
- CTRI/2019/12/022249
- Lead Sponsor
- Govt siddha medical college
- Brief Summary
This is a single non randomised open clinical trial to study the safety and efficacy of siddha trial drug mithran ambu chooranam. The trial drug is given 2.6 gm twice a day with palm jagggery for 10 days. clinical trial is conducted after conducting preclinical and toxicity study. The trial drug mithran ambu chooranam is mentioned in Anuboga vaithya perunkural. During the trial all the study related data will be recorded and documented after the completion of trial.All the data will be analysed statistically.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 20
presence of calculi in usg stone size 4 to 9 mm lower abdominal pain burning micturation oliguria dysurea haematuria.
Stag horn calculus calculi associated with elevated serum creatinine level pregnancy hydronephrosis obstructive neuropathy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is mainly assessed by reduction in clinical symptoms and by comparing the following parameters before and after treatments. 10 days
- Secondary Outcome Measures
Name Time Method Secondary outcome is assessed by comparing the safety parameters before and after treatment 1 year
Trial Locations
- Locations (1)
Arignar Anna Hospital of Indian Medicine
🇮🇳Chennai, TAMIL NADU, India
Arignar Anna Hospital of Indian Medicine🇮🇳Chennai, TAMIL NADU, IndiaDr Asai ManirajaPrincipal investigator8940838908asaimakeitsimple@gamil.com